The implementation of community-based diabetes and hypertension management care program in Indonesia


Autoři: Levina Chandra Khoe aff001;  Grace Wangge aff002;  Pradana Soewondo aff003;  Dicky L. Tahapary aff003;  Indah Suci Widyahening aff001
Působiště autorů: Community Medicine Department, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia aff001;  Southeast Asian Ministers of Education Organization – Regional Centre for Food and Nutrition (SEAMEO-RECFON)/Pusat Kajian Gizi Regional (PKGR), Universitas Indonesia, Jakarta, Indonesia aff002;  Division of Metabolic Endocrine, Department of Internal Medicine, Facuty of Medicine, Universitas Indonesia, Jakarta, Indonesia aff003
Vyšlo v časopise: PLoS ONE 15(1)
Kategorie: Research Article
doi: 10.1371/journal.pone.0227806

Souhrn

Since 2010, Indonesian government has initiated a chronic disease management program, Prolanis (Program Pengendalian Penyakit Kronis) targeted for diabetes and hypertension. The program is continued at the commencement of universal health coverage (UHC) in 2014. “This study aimed to report the utilization and cost of the implementation of Prolanis in Indonesia from 2014 to 2016, or two years since the commencement of Indonesian universal health coverage.” Secondary data analysis was performed using publicly available data and data obtained from the national health insurance agency (BPJS); while data on disease prevalence were collected from basic national health survey. There was an increase trend of Prolanis participants, from around 11,000 participants in 2014 to more than 250,000 in 2016. More than 70% of participants were adults living in Java, however, the acceptance rate was very low in other area. Across different activities in Prolanis, physical activity was the most participated ones. In comparison to other regions, regions in Java were the most active area. The total expenditure for Prolanis program in 2016 increased almost triple from the annual cost in 2014. However, the cost per person was actually decreased more than 50%. Within two years of UHC implementation, there were increase covered participants and total costs, but cost per individual was decreased and there was significant difference in of cost between Java and outside Java. Further study and routine monitoring-evaluation process by health authority is needed to assess whether the cost difference would affect the service quality.

Klíčová slova:

Diabetes mellitus – Epidemiology – Health education and awareness – Health insurance – Hypertension – Indonesia – Islands – Java


Zdroje

1. WHO. WHO | Integrated chronic disease prevention and control [Internet]. WHO. World Health Organization; 2010. http://www.who.int/chp/about/integrated_cd/en/. Last Accessed 26 Aug 2019.

2. BPJS Kesehatan. PROLANIS (Program Pengelolaan Penyakit Kronis) [Guideline]. https://bpjs-kesehatan.go.id/bpjs/dmdocuments/06-PROLANIS.pdf. Last Accessed 26 Aug 2019.

3. Assupina M, Rahmiwati A. Analisis Implementasi Program Pengelolaan Penyakit Kronis (Prolanis) Pada Dokter Keluarga Pt Askes Di Kota Palembang Tahun 2013 Analysis of Implementation of the Chronic Disease Management Program (Prolanis) At Family Doctor of PT Askes in Palembang O. J Ilmu Kesehat Masy. 2013;4: 254–261.

4. Indonesia NIHRD. Hasil Utama Riset Kesehatan Dasar 2018—Main Result of Indonesian Basic Health Survey 2018 [Internet]. 2018. http://www.depkes.go.id/resources/download/info-terkini/materi_rakorpop_2018/Hasil%20;Riskesdas%20;2018.pdf. Last Accessed 26 Aug 2019.

5. Indonesia NIHRD. Riset Kesehatan Dasar 2013—Report of Indonesian Basic Health Survey 2013. 2013. http://www.depkes.go.id/resources/download/general/Hasil%20Riskesdas%202013.pdf. Last Accessed at 26 Aug 2019.

6. Indonesia Central Statistic Agency. Indonesia Population Projection 2010–2035 [Internet]. Bps. 2017. https://www.bps.go.id/publication/2013/10/07/053d25bed2e4d62aab3346ec/proyeksi-penduduk-indonesia-2010-2035.html. Last Accessed at 26 Aug 2019.

7. Dyanneza F, Tamtomo D–S. The Effectiveness of Chronic Disease Management Program in Blood Pressure Control among Hypertensive Patients. Indones J Med. 2017;02: 52–62. doi: 10.26911/theijmed.2016.01.03.06


Článek vyšel v časopise

PLOS One


2020 Číslo 1